Evaluating Acalabrutinib In The Treatment Of Mantle Cell Lymphoma: Design, Development, And Place In Therapy

Mantle cell lymphoma (MCL) is an incurable intermediate-grade lymphoma representing 5–6% of non-Hodgkin’s lymphomas diagnosed in the United States. The introduction of inhibitors of Bruton’s tyrosine kinase (BTK) into targeted therapy for MCL has significantly improved outcomes in patients with rela...

全面介紹

Na minha lista:
書目詳細資料
發表在:Onco Targets Ther
Main Authors: Girard, Jennifer, Reneau, John, Devata, Sumana, Wilcox, Ryan A, Kaminski, Mark S, Mercer, Jessica, Carty, Shannon, Phillips, Tycel J
格式: Artigo
語言:Inglês
出版: Dove 2019
主題:
Review
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6777435/
https://ncbi.nlm.nih.gov/pubmed/31686856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S155778
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍